CIK 0001427925
- Non-accelerated filer
- Smaller reporting company
TALPHERA, INC.
Sign in to watch- Ticker
- TLPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412193603
- Phone
- +1 650-216-3500
- Business address
- 1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
- Former names
- ACELRX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-11 | Palmer Pamela P Chief Medical Officer | Shares withheld for taxes | −7,927 | $0.40 | $3K | 777,184 |
| 2022-02-11 | Palmer Pamela P Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +245,000 | 245,000 | ||
| 2022-02-11 | Dasu Badri N Chief Engineering Officer | Grant or award | +97,500 | 301,822 | ||
| 2022-02-11 | Dasu Badri N Chief Engineering Officer | Shares withheld for taxes | −5,615 | $0.40 | $2K | 296,207 |
| 2022-02-11 | Dasu Badri N Chief Engineering Officer | Grant or award · Stock Option (Right to Buy) | +195,000 | 195,000 | ||
| 2022-02-11 | ASADORIAN RAFFI Chief Financial Officer | Grant or award | +117,500 | 376,015 | ||
| 2022-02-11 | ASADORIAN RAFFI Chief Financial Officer | Shares withheld for taxes | −7,927 | $0.40 | $3K | 368,080 |
| 2022-02-11 | ASADORIAN RAFFI Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +235,000 | 235,000 | ||
| 2022-02-11 | Angotti Vincent J. Chief Executive Officer | Grant or award | +390,000 | 1,006,628 | ||
| 2022-02-11 | Angotti Vincent J. Chief Executive Officer | Shares withheld for taxes | −23,058 | $0.40 | $9K | 983,570 |
| 2022-02-11 | Angotti Vincent J. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +780,000 | 780,000 | ||
| 2022-02-06 | Palmer Pamela P Chief Medical Officer | Shares withheld for taxes | −9,391 | $0.43 | $4K | 662,611 |
| 2022-02-06 | Dasu Badri N Chief Engineering Officer | Shares withheld for taxes | −6,830 | $0.43 | $3K | 204,322 |
| 2022-02-06 | ASADORIAN RAFFI Chief Financial Officer | Shares withheld for taxes | −9,391 | $0.43 | $4K | 258,515 |
| 2022-02-06 | Angotti Vincent J. Chief Executive Officer | Shares withheld for taxes | −27,318 | $0.43 | $12K | 616,628 |
| 2021-11-20 | Broadfoot Jill Marie Director | Grant or award | +15,000 | 15,000 | ||
| 2021-11-20 | Broadfoot Jill Marie Director | Grant or award · Stock Option (Right to Receive) | +30,000 | 30,000 | ||
| 2021-06-17 | WAN MARK A Director | Grant or award | +10,000 | 21,250 | ||
| 2021-06-17 | WAN MARK A Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-06-17 | ADAMS ADRIAN Director | Grant or award | +10,000 | 196,250 |
Page 10 of 17 · 329 trades